Callan JMB

Callan JMB Equity Growth

The Year-over-Year Equity Growth of Callan JMB (CJMB) as of Nov 14, 2026 is -26.64 %. In the previous year, Year-over-Year Equity Growth was -63.92 % — a change of -58.33% (higher).

Equity Growth

-26.64 %

YoY

-58.33%

Last updated:

Year-over-Year Equity Growth of Callan JMB is 2025 -26.64 % . Year-over-Year Equity Growth of Callan JMB was 2024 -63.92 % . It decreases by -58.33% higher compared to the previous year.

The Callan JMB Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2023
-37.23 USD
Jan 1, 2024
-63.92 USD
Jan 1, 2025
-26.64 USD
The Callan JMB Equity Growth history
YEAREquity GrowthYoY
-26.64 %-58.33%
-63.92 %+71.71%
-37.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Callan JMB Stock analysis

What does Callan JMB do? Callan JMB Inc provides thermal management logistics solutions for the life sciences industry, including personalized medicine, cell therapies, and vaccines. The company's Ship2Q ultraviolet disinfection process ensures thermal reliability and cleanliness of packaging systems. Its vertically integrated model combines proprietary packaging, IT, and cold chain logistics expertise to serve clients requiring cryogenic or frozen shipping. The firm targets life sciences companies needing specialized shipping solutions for temperature-sensitive products. Callan JMB Inc's primary products include thermal management logistics services and the Ship2Q disinfection process. These solutions address the full range of frozen shipping needs in the life sciences sector. The company serves manufacturers of biopharmaceuticals, diagnostic materials, and other temperature-sensitive commodities. Its services ensure that shipping systems meet manufacturer specifications for fitness and thermal performance. The company's business model focuses on providing comprehensive alternatives to traditional logistics solutions for frozen shipping. It operates as a vertically integrated provider, handling all aspects of cold chain logistics from packaging to delivery. Callan JMB Inc's target clients are life sciences companies requiring reliable, temperature-controlled shipping for sensitive materials like cell lines, cord blood, and organs. The firm's proprietary technology differentiates it in the specialized logistics market. Callan JMB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Callan JMB stock

Year-over-Year Equity Growth of Callan JMB is -26.64 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Callan JMB since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Callan JMB historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Callan JMB

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Callan JMB